Moneycontrol
HomeNewsTrendsEntertainmentCoronavirus impact: Theatres see few takers for old content on day one of reopening
Trending Topics

Coronavirus impact: Theatres see few takers for old content on day one of reopening

Day One was expectedly low key with not many film buffs rushing to theatres. But the weekend beckons, and things may look up yet

October 15, 2020 / 18:30 IST
Story continues below Advertisement
Representative image

Empty auditoriums, old movies and limited food and beverage options --- that's what greeted movie-goers on the first day of reopening after a nearly-seven-month-long shutdown due to the coronavirus-led lockdown.

Despite the go-ahead from the central government to resume operations, not all theatres have reopened. And the crowds are not flocking in yet to those that have.

Story continues below Advertisement

Among multiplexes, PVR will open for the public tomorrow and, in a kind of cheery morale-booster, it has dedicated the first day of reopening to its employees and COVID-19 warriors.

In Bengaluru, two theatres each of INOX and Cinepolis reopened on October 15 while the rest are getting ready to resume operations.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show